BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8114526)

  • 21. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J
    Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
    [No Abstract]   [Full Text] [Related]  

  • 22. Myasthenia gravis: a cure is in sight.
    Wilson W
    Nurs Mirror; 1979 Jan; 148(1):17-20. PubMed ID: 252067
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A; Scherini A; Carbonera D; Mapelli A; Bellinzona G; Bobbio Pallavicini F; Dionigi R; Gasperi A
    Minerva Anestesiol; 1979 Nov; 45(11):871-81. PubMed ID: 548812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensive care in myasthenic and cholinergic crises].
    Popova LM; Piradov MA
    Anesteziol Reanimatol; 1996; (2):13-5. PubMed ID: 8754165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myasthenia gravis].
    Gajdos P
    Rev Prat; 2002 Jan; 52(1):71-7. PubMed ID: 11852770
    [No Abstract]   [Full Text] [Related]  

  • 27. Current treatment of myasthenia gravis.
    Osterman PO
    Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293
    [No Abstract]   [Full Text] [Related]  

  • 28. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW
    Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract]   [Full Text] [Related]  

  • 29. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)].
    Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Shagal DI; Zaĭrat'iants OV; Khodzhaev ZSh; Ippolitov IKh
    Khirurgiia (Mosk); 1990 Aug; (8):95-9. PubMed ID: 2259184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R; Haferkamp G
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
    [No Abstract]   [Full Text] [Related]  

  • 34. Myasthenia gravis.
    Barboi AC; Meriggioli MN
    Clin Neuropharmacol; 2000; 23(6):291-5. PubMed ID: 11575862
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and treatment of myasthenia gravis.
    Tindall RS
    Compr Ther; 1981 May; 7(5):33-43. PubMed ID: 7237990
    [No Abstract]   [Full Text] [Related]  

  • 36. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L; Horváth R; Bárdosi Z; Szobor A
    Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy].
    Marchuk AI; Golovteev VV; Sapin SM; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of autoimmune myasthenia].
    Pénisson-Besnier I
    Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.